DMAC vs ITW · $157.4M cap vs P/E 22, rev $16.04B
DiaMedica Therapeutics Inc (DMAC) versus Illinois Tool Works Inc (ITW) — a side-by-side from cached financials, not a winner call.
DiaMedica Therapeutics Inc (DMAC) is a biotechnology company listed on US.
Illinois Tool Works Inc (ITW) is a specialty industrial machinery company listed on US.
DMAC does not have a complete income-statement cache yet.
Latest reported ITW revenue for 2025-12-31 was $16.04B. Net income was $3.07B. Revenue was up 0.9% from 2024-12-31 to 2025-12-31. ITW currently screens at market cap $72.53B and trailing P/E 21.8.
DMAC currently screens at market cap $157.4M. ITW currently screens at market cap $72.53B and trailing P/E 21.8.
Not investment advice. Open the DMAC and ITW stock pages for the full models.
Not investment advice.